-
David Flores Co-Founder, President & CEO, BioCentury
Lesson from Boston. Biocluster success factor
- Co-Founder, President & CEO, BIOCENTURY
- Advisory Board, Innovation and New Ventures Office (INVO) at Northwestern University Advisory Council, Keck Graduate Institute of the Applied Life Sciences
- Management Board, Stanford Graduate School of Business
- Co-Founded BioCentury with Karen Bernstein
- MBA, Stanford University.
- University of California at Berkeley -
Michael Chen Head of External Innovation APAC, MERCK KGaA
MERCK's Innovative New Drug Pipeline and Global Strategy, Trends of European Bio Clusters- Head of External Innovation APAC for MERCK KGaA
- Business Development/investment, WuXi AppTec and ChemPartner
- Lead Research projects at Spirogen Ltd./MedImmune (UK)
- PhD in Biochemistry, Imperial College London
- MS in cancer immunotherapy, University of Nottingham
- BS in cell and molecular biology, University of Essex -
Sharon Chan Head JLABS @ Shanghai, Johnson and Johnson
Johnson and Johnson JLABS: Building an innovative ecosystem- Board Director, Right 2 Thrive, New York and Kenya
- Head of Asia at Aeras, Beijing
- Business Development roles at Baxter Healthcare in Shanghai and Sosei in London
- MPH, Johns Hopkins University at Bloomberg School of Public Health
- MBA, IE Business School, Madrid
- DPhil, MBioChem, University of Oxford -
Suk Yun Gang Director, Biopharmaceuticals and Herbal Medicine Bureau, Ministry of Food and Drug Safety
Escalating biocluster, What are the changes from Advanced Biotechnology Act- Director, Biopharmaceuticals and Herbal Medicine Bureau, Ministry of Food and Drug Safety
- Chief, Biopharmaceutical Policy Division, Ministry of Food and Drug Safety
- Chief, Narcotics Policy Division, Ministry of Food and Drug Safety
- BS, MS, PhD from College of Pharmacy, Chung-Ang University -
Kim Tae Eok KDDF Director
Taking a deep breath to Bio industry, wisdom to overcome the crisis- Chief Business Officer, Korea Drug Development Fund
- Chief Science Officer,, Minsrtry of Food and Drug Safrty
- CEO, K2B
- Senior PM, INNOPOLIS Foundation
- Senior Researcher, Korea Research Institute of Bioscience & Biotechnology
- PhD in Economics, University of Leeds
- Masters in Economics, The University of Manchester -
Changjoon Justin Lee Director of IBS Center for Cognition and Sociality
Targeting reactive astrocyte to develop Alzheimer's disease drugs.- Director, Center for Cognition and Sociality, IBS
- Director, Brain Science Institute, KIST
- Editor-in-chief, Experimental Neurobiology
- Faculty researcher, KU-KIST Graduate School
- Professor, University of Science and Technology
- PhD, Columbia University
- B.S. in Chemistry, The University of Chicago